Ernest Mceachern News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Ernest Mceachern. Real-time updates on events, politics, business and more.

Biogen, Alectos collaborate to develop Parkinson's disease treatment

June 8, 2022

Biogen has entered into a license and collaboration agreement with Alectos Therapeutics to develop and commercialise AL01811 to treat PD.

Priya Singhal Ernest Mceachern Milling Technology For Pharmaceuticals Alectos Therapeutics Packaging Products Wet Milling Technology

Source: pharmaceutical-technology.com

Biogen Inc.: Biogen and Alectos Therapeutics Announce License and Collaboration Agreement for AL01811, a Novel GBA2 Inhibitor for the Potential Treatment of Parkinson's Disease

June 6, 2022

AL01811 is a preclinical selective GBA2 inhibitor with first-in-class potential as an oral disease modifying treatment for Parkinson's DiseaseAlectos to receive a $15 million upfront payment and is eligible

United Kingdom Walter Gilbert Charles Weissmann Heinz Schaller Ernest Mceachern Ashleigh Koss

Source: finanznachrichten.de

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Ernest Mceachern News Today

Biogen, Alectos collaborate to develop Parkinson's disease treatment

Biogen Inc.: Biogen and Alectos Therapeutics Announce License and Collaboration Agreement for AL01811, a Novel GBA2 Inhibitor for the Potential Treatment of Parkinson's Disease

Explore More Categories